Your browser doesn't support javascript.
loading
Epigenetic Fingerprint of the SARS-CoV-2 Infection in the Lung of Lethal COVID-19.
Noguera-Castells, Aleix; Parra, Jerónimo; Davalos, Veronica; García-Prieto, Carlos A; Veselinova, Yoana; Pérez-Miés, Belén; Caniego-Casas, Tamara; Palacios, José; Saenz-Sardà, Xavier; Englund, Elisabet; Musulen, Eva; Esteller, Manel.
Afiliación
  • Noguera-Castells A; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain; Centro de Investig
  • Parra J; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain.
  • Davalos V; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain.
  • García-Prieto CA; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona, Catalonia, Spain.
  • Veselinova Y; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain.
  • Pérez-Miés B; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henare
  • Caniego-Casas T; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Palacios J; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Department of Pathology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain; Department of Medicine and Medical Specialties, University of Alcalá, Alcalá de Henare
  • Saenz-Sardà X; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Englund E; Division of Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Musulen E; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Department of Pathology, Hospital Universitari General de Catalunya Grupo-QuirónSalud, Barcelona, Catalonia, Spain.
  • Esteller M; Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Vic, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Physiological Sciences Dep
Chest ; 165(4): 820-824, 2024 Apr.
Article en En | MEDLINE | ID: mdl-37914026
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Chest Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Chest Año: 2024 Tipo del documento: Article